Retrospective study of guideline concordance in cervical cancer screening surveillance by age, race, and ethnicity.

5525 Background: Nearly one in five new cervical cancer cases occur in individuals aged ≥ 65, with higher incidence among Black women compared to White women. Despite these disparities, evidence guiding screening and surveillance in older women is limited. This study evaluates guideline concordance for follow-up after abnormal cervical cancer screening and examines variation by age, race, and ethnicity. Methods: This retrospective cohort study assessed 1,861,906 cervical cancer screening results (2009-2024) from the TrinetX database. Included patients were female, ≥ 21 years old, and had an HPV test or pap smear. Guideline concordance (i.e., colposcopy within one year of high-risk cervical cancer screenings result) was assessed by running logistic regression models by age group, race, and ethnicity. Logistic regression assessed odds of concordant follow-up by age, race, and ethnicity, using women aged 30–39 and non-Hispanic White women as reference groups, respectively. Results: Guideline-concordant follow-up varied by age: 56.87% aged 21-29, 58.84% aged 30-39, 56.36% aged 40-49, 53.93% aged 50-65, and 45.80% aged 65+. Compared with women aged 30-39, both younger and older women were significantly less likely to receive guideline concordant follow-up. Women 65+ had 44% lower odds of concordant follow-up (OR= 0.56, 95% CI 0.53 to 0.60, p<.001). Guideline-concordant care also varied by race and ethnicity: 51.11% of non-Hispanic Black, 56.65% of non-Hispanic Asian, 60.36% of non-Hispanic White, 58.43% of non-Hispanic Other, and 51.71% of Hispanic patients. Compared to non-Hispanic White women, all other groups had significantly lower odds of follow-up, with non-Hispanic Black women having 30% lower odds (OR = 0.70, 95% CI 0.68 to 0.72, p<.001) and Hispanic women having 28% lower odds (OR= 0.72, 95% CI 0.71 to 0.74, p<.001) of concordant follow-up. Conclusions: Overall, the rate of guideline concordant follow-up after high-risk cervical cancer screening results was low (57.83%) and declined with age, with lowest rates among women ≥ 65 (45.80%). All other age groups had significantly lower odds of concordance than those 30-39, with those 65+ having the lowest odds of concordance. Significant disparities were also observed by race and ethnicity, particularly among non-Hispanic Black and Hispanic women. Further research is needed to assess the decreased surveillance rates after high-risk cervical cancer screening results at the population level and specific attention should be focused on groups who have been under-surveilled.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-05-27
DOI
https://doi.org/10.1200/jco.2026.44.16_suppl.5525
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retrospective study of guideline concordance in cervical cancer screening surveillance by age, race, and ethnicity.

Shifa Hossain, Edward Gemson, Rulla Tamimi, Maeve Fitzgerald Givens
Journal of Clinical Oncology
Cervical Cancer and HPV Research
article

Retrospective study of guideline concordance in cervical cancer screening surveillance by age, race, and ethnicity.

Shifa Hossain, Edward Gemson, Rulla Tamimi, Maeve Fitzgerald Givens
article en

Abstract

5525 Background: Nearly one in five new cervical cancer cases occur in individuals aged ≥ 65, with higher incidence among Black women compared to White women. Despite these disparities, evidence guiding screening and surveillance in older women is limited. This study evaluates guideline concordance for follow-up after abnormal cervical cancer screening and examines variation by age, race, and ethnicity. Methods: This retrospective cohort study assessed 1,861,906 cervical cancer screening results (2009-2024) from the TrinetX database. Included patients were female, ≥ 21 years old, and had an HPV test or pap smear. Guideline concordance (i.e., colposcopy within one year of high-risk cervical cancer screenings result) was assessed by running logistic regression models by age group, race, and ethnicity. Logistic regression assessed odds of concordant follow-up by age, race, and ethnicity, using women aged 30–39 and non-Hispanic White women as reference groups, respectively. Results: Guideline-concordant follow-up varied by age: 56.87% aged 21-29, 58.84% aged 30-39, 56.36% aged 40-49, 53.93% aged 50-65, and 45.80% aged 65+. Compared with women aged 30-39, both younger and older women were significantly less likely to receive guideline concordant follow-up. Women 65+ had 44% lower odds of concordant follow-up (OR= 0.56, 95% CI 0.53 to 0.60, p<.001). Guideline-concordant care also varied by race and ethnicity: 51.11% of non-Hispanic Black, 56.65% of non-Hispanic Asian, 60.36% of non-Hispanic White, 58.43% of non-Hispanic Other, and 51.71% of Hispanic patients. Compared to non-Hispanic White women, all other groups had significantly lower odds of follow-up, with non-Hispanic Black women having 30% lower odds (OR = 0.70, 95% CI 0.68 to 0.72, p<.001) and Hispanic women having 28% lower odds (OR= 0.72, 95% CI 0.71 to 0.74, p<.001) of concordant follow-up. Conclusions: Overall, the rate of guideline concordant follow-up after high-risk cervical cancer screening results was low (57.83%) and declined with age, with lowest rates among women ≥ 65 (45.80%). All other age groups had significantly lower odds of concordance than those 30-39, with those 65+ having the lowest odds of concordance. Significant disparities were also observed by race and ethnicity, particularly among non-Hispanic Black and Hispanic women. Further research is needed to assess the decreased surveillance rates after high-risk cervical cancer screening results at the population level and specific attention should be focused on groups who have been under-surveilled.

Journal of Clinical OncologyVol. 44(16_suppl)
Cornell University (US), Weill Cornell Medicine (US)
Openalex Percentile: Top 7%
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.